Orthofix Medical Stock Performance
| OFIX Stock | USD 15.06 0.19 1.25% |
On a scale of 0 to 100, Orthofix Medical holds a performance score of 17. The company holds a Beta of 0.56, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Orthofix Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Orthofix Medical is expected to be smaller as well. Please check Orthofix Medical's downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to make a quick decision on whether Orthofix Medical's historical price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Orthofix Medical are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Orthofix Medical showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 37.8 M | |
| Total Cashflows From Investing Activities | -27.6 M |
Orthofix Medical Relative Risk vs. Return Landscape
If you would invest 1,067 in Orthofix Medical on July 20, 2025 and sell it today you would earn a total of 439.00 from holding Orthofix Medical or generate 41.14% return on investment over 90 days. Orthofix Medical is currently generating 0.5638% in daily expected returns and assumes 2.6068% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Orthofix, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Orthofix Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orthofix Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Orthofix Medical, and traders can use it to determine the average amount a Orthofix Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2163
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OFIX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.61 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Orthofix Medical is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orthofix Medical by adding it to a well-diversified portfolio.
Orthofix Medical Fundamentals Growth
Orthofix Stock prices reflect investors' perceptions of the future prospects and financial health of Orthofix Medical, and Orthofix Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Orthofix Stock performance.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.0595 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | (0.08) % | |||
| Current Valuation | 700.35 M | |||
| Shares Outstanding | 39.49 M | |||
| Price To Earning | 338.00 X | |||
| Price To Book | 1.22 X | |||
| Price To Sales | 0.74 X | |||
| Revenue | 799.49 M | |||
| EBITDA | (34.18 M) | |||
| Cash And Equivalents | 59.54 M | |||
| Cash Per Share | 2.98 X | |||
| Total Debt | 179.63 M | |||
| Debt To Equity | 0.08 % | |||
| Book Value Per Share | 11.61 X | |||
| Cash Flow From Operations | 25.79 M | |||
| Earnings Per Share | (3.17) X | |||
| Total Asset | 893.29 M | |||
| Retained Earnings | (276.14 M) | |||
| Current Asset | 147.87 M | |||
| Current Liabilities | 52.94 M | |||
About Orthofix Medical Performance
Evaluating Orthofix Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Orthofix Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Orthofix Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Orthofix Intl operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1087 people.Things to note about Orthofix Medical performance evaluation
Checking the ongoing alerts about Orthofix Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Orthofix Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 799.49 M. Net Loss for the year was (126 M) with profit before overhead, payroll, taxes, and interest of 557.23 M. | |
| Over 93.0% of the company shares are owned by institutional investors |
- Analyzing Orthofix Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Orthofix Medical's stock is overvalued or undervalued compared to its peers.
- Examining Orthofix Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Orthofix Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Orthofix Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Orthofix Medical's stock. These opinions can provide insight into Orthofix Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.